In colorectal cancer, metabolic enzymes such as SHMT2, LDHB, and TFEB are selectively targeted through acetylation-dependent degradation or stabilization, reflecting the metabolic vulnerability of this tumor type. The gene discussed is LDHB; the disease is colorectal cancer.